A comparison of ARMS and direct sequencing for EGFR mutation analysis and tyrosine kinase inhibitors treatment prediction in body fluid samples of non-small-cell lung cancer patients.
about
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancerOsimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapyA prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)Peripheral blood for epidermal growth factor receptor mutation detection in non-small cell lung cancer patients.Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR statusKRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinomaEpidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients.Epidermal growth factor receptor mutation analysis in cytological specimens and responsiveness to gefitinib in advanced non-small cell lung cancer patientsThe role of molecular pathology in non-small-cell lung carcinoma-now and in the future.Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer.The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China.Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assayQuantification of EGFR mutations in primary and metastatic tumors in non-small cell lung cancerEGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma.A Sensitive Peptide Nucleic Acid Probe Assay for Detection of BRAF V600 Mutations in Melanoma.Liquid Biopsies in the Screening of Oncogenic Mutations in NSCLC and its Application in Targeted Therapy.Different treatment orders achieved similar clinical results: a retrospective study for retreatment of epidermal growth factor receptor tyrosine kinase inhibitors in 120 patients with non-small-cell lung cancer.The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysisMolecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger Sequencing.EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.Immunohistochemistry with a novel mutation-specific monoclonal antibody as a screening tool for the EGFR L858R mutational status in primary lung adenocarcinoma.[Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer].Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer.Somatic mutation analysis of KRAS, BRAF, HER2 and PTEN in EGFR mutation-negative non-small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel deletion in HER2 gene from Indian patients.Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS.
P2860
Q28079253-B41BF6D0-E3A3-42E5-9249-7487F889B477Q33757134-A7913182-CD5A-4EE9-8E34-8C9142637915Q34041754-9CCD5383-021B-4433-A50A-2D29C18E3045Q34092157-A3979008-B295-4B63-A39F-20A5BCB7EF24Q34473831-61DAD22C-3D98-4185-ACC0-92E3BA5E8F26Q34748747-E431694D-DD41-4EF4-84DC-2A443079E6CEQ35077521-43C0154D-FB4C-4E27-9F81-0F1F8605B6E6Q35204324-19365D2C-5F3A-427B-B9F1-178FA2ACA861Q35812818-AF791CB0-1E1B-4F00-BA7E-C5A27B2306CAQ36040599-3A25FF23-DD4A-4BAF-91EA-A14271D5C8B2Q36439401-B8093A10-E23D-4753-82DA-D4A22A5E94AAQ37365512-52E957EF-8CBC-41B1-9DA9-332263931AAFQ37407368-9BA31824-804C-4196-B230-F5179E31AA87Q37480093-DBCDC96E-F87A-434F-B7C3-8A06E0AC44D4Q37566609-29BD7B32-AC2B-4AD4-B7BC-E5E6D98EEEC0Q37706284-5AEB4780-340D-46D4-BBC9-453691CC5D5DQ38749766-F440898E-75EE-41AD-BC41-EBC2D5E51EACQ38859701-D1E9331E-F5B6-4049-BA4F-4B26C72C31B5Q39277085-FCB700BB-F915-4AD6-A230-B8674D840E39Q41153904-74575236-8761-4582-9985-411FB3EDF9AAQ41709088-5A50D211-D227-4DBF-8AE0-F26C37EB0574Q44070495-4D077B06-FB20-4DB3-8C1A-BC230B9A560DQ47198852-C1AF26AE-2523-4761-8CB0-AA64AA27B394Q49959764-69ED30C4-8879-4CEF-9DFA-C996DDA1903DQ51046274-7FA2E39A-5ED8-41CF-9DD6-2045CE3504FFQ51057061-FC76BC2F-83B7-4C25-A9CC-68455990D2F6Q51139197-5C241835-2125-4095-9413-9C4D9A951A68Q51497614-5AB5EC7B-0856-4FE7-B115-FEC4563E3C70Q54117313-956D4A56-DD5B-4C2B-8FA9-E3F5B71F0CBF
P2860
A comparison of ARMS and direct sequencing for EGFR mutation analysis and tyrosine kinase inhibitors treatment prediction in body fluid samples of non-small-cell lung cancer patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A comparison of ARMS and direc ...... all-cell lung cancer patients.
@en
type
label
A comparison of ARMS and direc ...... all-cell lung cancer patients.
@en
prefLabel
A comparison of ARMS and direc ...... all-cell lung cancer patients.
@en
P2093
P2860
P356
P1476
A comparison of ARMS and direc ...... all-cell lung cancer patients.
@en
P2093
Chuan-Hao Tang
Cui-Jing Chen
Hai-Feng Qin
Hong-Jun Gao
Jian-Jie Li
Wan-Feng Guo
Xiao-Qing Liu
P2860
P2888
P356
10.1186/1756-9966-30-111
P577
2011-12-06T00:00:00Z
P5875
P6179
1050317244